Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Win

20 Nov 2008 07:00

RNS Number : 5213I
e2v technologies PLC
20 November 2008
Β 

ο»Ώ

20Β NovemberΒ Β 2008Β 

e2v technologies plc

Contract WinΒ 

e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces anΒ Β£11mΒ contract renewal to supply Varian Medical Systems,Β Inc., headquartered in Palo Alto, US, with electronΒ devicesΒ for incorporation into linear accelerators, for use in radiotherapy cancer treatmentΒ and cargo screeningΒ systems.

The contractΒ will beΒ worth at leastΒ Β£11mΒ (payments will be in USΒ dollarsΒ at the prevailing exchange rate)Β over twoΒ years, and is the first of a number of anticipated multi-year contract renewals for electronΒ devicesΒ used in linear accelerators. e2v's productsΒ generateΒ and deliver the microwave power requiredΒ fromΒ the linear acceleratorΒ to produce X-rays usedΒ inΒ both the imaging and radiation treatment of tumoursΒ as well asΒ the imaging systems withinΒ cargo screeningΒ equipment.

ThisΒ contractΒ represents anΒ increase in businessΒ with this customer,Β has the potential to increase in value over the termΒ of the agreement, and is in line with management'sΒ growth expectations for this sector.

Keith Attwood, Chief Executive of e2vΒ said: ``This multi-year contract renewal with Varian is a demonstration of the strongΒ and closeΒ relationships we build with our strategic partners.''

For further information:

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Mike Hannant

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7269 7225

Jon Simmons/Sophie Kernon

Β Β Β 

NOTES FOR EDITORS

e2vΒ 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliabilityΒ mission-critical programsΒ in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of Β£205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's firstΒ USΒ manufacturing base.Β 

The Company is headquartered in theΒ United KingdomΒ and has approximately 1800 employees in six production facilities across Europe andΒ North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available fromΒ www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTFKCKDABDDFDD
Date   Source Headline
15th Dec 20162:41 pmRNSForm 8.3 - E2V Technologies PLC
15th Dec 20161:19 pmRNSForm 8.3 - e2v Technologies plc
15th Dec 20169:00 amRNSForm 8.5 (EPT/RI)
14th Dec 20165:22 pmRNSForm 8.3 - e2e technologies PLC
14th Dec 20165:15 pmRNSForm 8.3 - E2V TECHNOLOGIES PLC
14th Dec 20163:07 pmRNSHolding(s) in Company
14th Dec 20161:19 pmPRNForm 8.3 - e2v technologies plc
14th Dec 20169:45 amRNSForm 8.3 - E2V Technologies
14th Dec 20168:37 amBUSForm 8.3 - E2V Technologies PLC
13th Dec 20163:27 pmRNSForm 8.3 - E2V Technologies Plc
13th Dec 20163:20 pmRNSRule 2.9 Announcement
13th Dec 20163:20 pmRNSForm 8.3 - e2v Technologies Plc
13th Dec 20162:52 pmRNSForm 8.3 - e2v technologies plc
13th Dec 20162:15 pmRNSForm 8.3 - e2v Technologies Plc
13th Dec 20162:02 pmRNSForm 8.3 - [e2v Technologies plc]
13th Dec 201611:50 amRNSForm 8.3 - e2v Technologies plc
13th Dec 201611:16 amRNSForm 8.3 - E2V Technologies
13th Dec 201611:02 amRNSForm 8.3 - E2V Technologies Plc
13th Dec 20169:04 amBUSForm 8.3 - E2V Technologies PLC
13th Dec 20168:52 amRNSForm 8.5 (EPT/RI)
12th Dec 20163:44 pmRNSForm 8.3 - e2v Technologies Plc
12th Dec 20163:07 pmRNSForm 8.3 - E2V Technologies Plc
12th Dec 201610:39 amPRNRule 8.3 - E2V Technologies PLC
12th Dec 20169:49 amRNSForm 8.3 - e2v technologies plc
12th Dec 20167:00 amRNSRecommended Cash Acquisition
8th Dec 20169:08 amRNSTotal Voting Rights
28th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 20165:03 pmRNSHolding(s) in Company
10th Nov 20165:29 pmRNSHolding(s) in Company
8th Nov 201612:06 pmRNSHolding(s) in Company
8th Nov 20169:21 amRNSTotal Voting Rights
7th Nov 201611:20 amRNSPDMR Share Purchase
7th Nov 201610:37 amRNSPDMR Share Purchase
7th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20163:54 pmRNSDirectorate Change
14th Oct 20169:15 amRNSBlock listing return
11th Oct 20162:48 pmRNSDirectorate Change
3rd Oct 20169:27 amRNSTotal Voting Rights
21st Sep 20163:12 pmRNSHolding(s) in Company
5th Sep 20163:09 pmRNSReplacement - Total Voting Rights
5th Sep 20161:30 pmRNSTotal Voting Rights
30th Aug 201612:29 pmRNSHolding(s) in Company
25th Aug 201610:11 amRNSInvestor site visit and presentation
8th Aug 20161:05 pmRNSTotal Voting Rights
19th Jul 20161:11 pmRNSHolding(s) in Company
14th Jul 20168:48 amRNSResult of AGM
13th Jul 20167:00 amRNSDirectorate Change
13th Jul 20167:00 amRNSAGM Update
11th Jul 20169:03 amRNSDirectorate Change
6th Jul 201612:18 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.